The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.
Montagnon. B J BJ; Fanget. B B; Nicolas. A J AJ
Key Findings
- VERO cells can replace primary monkey kidney cells for producing killed poliovirus vaccine.
- Using micro‑carrier culture, over 400 billion cells per week can be grown at high density.
- Virus yield per VERO cell is at least as high as with monkey kidney cells, and production appears economically feasible.
- Further safety testing is still needed before widespread adoption.
Practical Outcomes
- For biohackers and citizen scientists, this study offers no direct protocol or dosage information you can use. It mainly informs that large‑scale vaccine manufacturing can move away from animal sources, which may affect future vaccine availability but does not translate into actionable personal health strategies.
Summary
Scientists showed that a lab-grown cell line called VERO can be used instead of monkey kidneys to make large amounts of killed polio vaccine, producing lots of cells and virus without losing yield, but this is a manufacturing method, not something you can apply to personal health or DIY experiments.
Abstract
As the increasing shortage of monkeys is a reality, the application of an alternative cell substrate for large-scale production of Killed Poliomyelitis Vaccine (KPV) was studied. Through progress of scientific knowledge the non-tumorigenic VERO cell line was considered to be a suitable alternative cell substrate for this purpose. The Master-Cell-Bank and Working-Cell-Banks prepared by us are giving a practically inexhaustible cell source. Using micro-carrier culture, weekly more than 400 billions of cells at a concentration of 10(6) cells per ml could be obtained for virus inoculation. The virus yield per cell was at least as high as for primary monkey kidney cells. Processing of virus harvests could be performed according to the methods used at the production on primary monkey kidney cells. From a technological view-point large-scale production of KPV on VERO cells appears to be possible economically. More research on the safety control might be necessary.
Study Information
pubmed
1981